Buy LGD-4033 (Ligandrol) 10mg x30 Capsules

LGD-4033 (Ligandrol) is a non-steroidal selective androgen receptor modulator developed by Ligand Pharmaceuticals. In a Phase I clinical trial at 1mg/day for 21 days, lean mass increases of 1.21kg were observed — exceeding what testosterone produces at equivalent suppression levels. At research doses of 5-10mg/day, LGD-4033 is the most potent lean mass SARM in the current research catalog.

▸Phase I Clinical Data

The Viking Therapeutics Phase I trial at 1mg/day demonstrated dose-dependent lean mass gains with a favorable safety profile over 21 days. Muscle biopsies showed increased protein synthesis rates. Testosterone suppression was dose-dependent and reversible — testosterone returned to baseline within 5 weeks of discontinuation at 1mg/day.

▸Potency and Risk Profile

LGD-4033 is more suppressive than Ostarine at equivalent doses — post-cycle therapy (PCT) is strongly recommended for cycles exceeding 6 weeks, particularly at 5-10mg/day. The suppression is well-characterized and reliably reversible, but the greater potency means more significant lean mass gains alongside more significant hormonal management requirements.

▸Body Recomposition

LGD-4033 excels at body recomposition — gaining lean mass while losing fat simultaneously. At 5mg/day in a moderate caloric deficit, users consistently report net lean tissue increases alongside visible fat reduction, which is uncommon with traditional anabolic compounds.